| FCNKX | RGAFX | FCNKX / RGAFX | |
| Total Expense Ratio | 0.67 | 0.34 | 197% |
| Annual Report Gross Expense Ratio | 0.67 | 0.34 | 197% |
| Fund Existence | 18 years | 24 years | - |
| Gain YTD | 6.719 | 5.757 | 117% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 173B | 357B | 48% |
| Annual Yield % from dividends | 0.00 | 0.48 | - |
| Returns for 1 year | 7.82 | 1.89 | 414% |
| Returns for 3 years | 68.34 | 37.15 | 184% |
| Returns for 5 years | 37.50 | 14.81 | 253% |
| Returns for 10 years | 161.86 | 102.61 | 158% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MLNSX | 28.94 | 0.32 | +1.12% |
| Morgan Stanley Instl Glbl Concntr R6 | |||
| CHTVX | 24.84 | 0.26 | +1.06% |
| Invesco Charter R5 | |||
| PRUFX | 107.67 | 0.90 | +0.84% |
| T. Rowe Price Growth Stock I | |||
| BIRAX | 24.95 | 0.17 | +0.69% |
| BlackRock Sust Awr Advtg Lg Cp Cr Inv A | |||
| BIPIX | 85.84 | -4.02 | -4.47% |
| ProFunds Biotechnology UltraSector Inv | |||